Podcasts · Science

Lung Cancer Considered

IASLC

300 episodes

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

More about the show

Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Episodes page 1 of 6

  1. LCC in Arabic: WCLC 2026 Highlights

    · 42 min

    The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  2. LCC in Mandarin: WCLC 2026 Highlights with Experts from Taiwan

    · 1 h 01 min

    The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  3. LCC in Hebrew: WCLC 2026 Highlights

    · 38 min

    The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  4. WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth

    · 19 min

    Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr.…

  5. LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026

    · 38 min

    The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the…

  6. LCC in Korean WCLC 2026 Highlights

    · 46 min

    The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast…

  7. WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care

    · 25 min

    In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that…

  8. WCLC 2026 East-West Academic Exchange: Collaborating on the Future of Lung Cancer Care

    · 34 min

    Recorded live at the IASLC World Conference on Lung Cancer (WCLC) 2026 in Seoul, this episode brings together experts from China and the U.S. to discuss the growing exchange of ideas, research, and clinical expertise…

  9. WCLC 2026 Nurse Practitioner Takeover: What APPs are Taking Back to the Clinic

    · 44 min

    Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Nurse Practitioner takeover episode looks at key developments in small cell lung cancer, antibody-drug conjugates, and lung cancer…

  10. LCC in Czech: WCLC 2026 Highlights

    · 11 min

    The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  11. LCC in Spanish: WCLC 2026 Highlights

    · 49 min

    The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  12. LCC in Portuguese: WCLC 2026 Highlights

    · 29 min

    The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  13. Live From WCLC 2026: Tuesday Highlights & Meeting Summary

    · 45 min

    In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu recap key findings from day three of the conference, featuring major advances that move targeted therapies…

  14. LCC in Mandarin: WCLC 2026 Highlights

    · 37 min

    The 2026 World Conference on Lung Cancer brings together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded…

  15. Live From WCLC 2026: Monday Highlights

    · 31 min

    In this special WCLC 2026 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference and ask what changes in clinic on Monday. A ROS1 drug that…

  16. Live From WCLC 2026: Sunday Highlights

    · 47 min

    From the IASLC 2026 World Conference on Lung Cancer (WCLC) in Seoul, Dr. Narjust Florez talks with Dr. Chad Rusthoven about MAVERICK, the trial that tested MRI surveillance alone against prophylactic cranial…

  17. Before You Go: A Practical Guide to WCLC 2026 in Seoul

    · 38 min

    Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez. From preparing for the flight and beating jet lag to navigating COEX, networking, exploring Seoul’s food scene,…

  18. Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

    · 48 min

    In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use…

  19. LCC in Korean: The Role of Immunotherapy in Lung Cancer

    · 47 min

    In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and Dr. Young Kwang Chae to discuss the evolving role of immunotherapy across the lung cancer treatment continuum.…

  20. The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro

    · 29 min

    Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respiratory Diseases, for a thought-provoking discussion on why lung cancer must be recognized as a global health…

  21. LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

    · 47 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilience. Drawing from…

  22. LCC Advances in ALK+ Cancer in Cantonese

    · 46 min

    As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The discussion…

  23. Treating Advanced Thymic Cancers

    · 59 min

    Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined by Dr. Nicolas…

  24. FDA Approval: Zidesamtinib and ROS1 NSCLC

    · 24 min

    Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephen Liu, Dr.…

  25. Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

    · 48 min

    How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest…

  26. IASLC - Your First Faculty Job

    · 42 min

    Starting your first faculty position can be both exciting and overwhelming. In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Arthi Sridhar to discuss the transition from fellowship to…

  27. Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

    · 46 min

    In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped modern lung cancer…

  28. Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

    · 39 min

    This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -…

  29. ASCO 2026 Highlights – Part 2: Emerging Immunotherapy Strategies in Lung Cancer

    · 40 min

    In Part 2 of the ASCO 2026 Highlights series, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Julie Brahmer and Dr. Solange Peters to discuss some of the most notable immunotherapy advances presented at…

  30. ASCO 2026 Highlights – Part 1: Landmark Advances in Targeted Therapy

    · 46 min

    In this Part 1 of 2 ASCO 2026 Highlights episodes, hosts Dr. Narjust Florez and Dr. Stephen Liu are joined by Dr. Alice Shaw and Dr. Jonathan Goldman to review some of the most impactful targeted therapy data presented…

  31. Patients, AI, and Lung Cancer: Finding Clarity in the Noise

    · 47 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Natalie Brown and Dr. Aurora Lucas to explore how patients and caregivers are using artificial intelligence in the context of lung cancer…

  32. LCC in Italian: Resectable EGFR-mutant NSCLC

    · 50 min

    As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Andrea Fillipi and Dr. Piergiorgio Solli. The tumor board focuses on the…

  33. LCC Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

    · 48 min

    This episode of Lung Cancer considered explores the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery,…

  34. AACR 2026 Highlights: KRAS Updates

    · 47 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses KRAS updates from the American Association for Cancer Research (AACR) 2026 Annual Meeting with Dr. Deborah Doroshow, Dr. David S. Hong, and Dr.…

  35. LCC in Spanish: Manejo perioperatorio en cáncer de pulmón en estadio temprano

    · 49 min

    This episode of Lung Cancer Considered, part of IASLC’s World Language Series, features host Dr. Narjust Florez leading a Spanish-language discussion with Dr. José Corona-Cruz and Dr. Diego Carrillo on perioperative…

  36. IASLC - Nursing & Allied Health in Lung Cancer Care and Clinical Research

    · 49 min

    This episode of LCC covers the work of our nursing and allied health professional committee and, most importantly, highlight their role in the care of patients with thoracic malignancies. Guests: Professor Nicole…

  37. IASLC - Lung Cancer Considered India

    · 43 min

    This episode of Lung Cancer Considered covers lung cancer in India and brings awareness about its first and largest advocacy group in the nation. To learn more about Lung Connect India, key members of the team will…

  38. LCC in Korean: A Case-Based Discussion on EGFR-Mutant NSCLC

    · 34 min

    As part of IASLC’s ongoing podcast series in world languages, Dr. Chul Kim moderates a discussion in Korean with Dr. Beung-Chul Ahn and Dr. Hyein Jeon. The session focuses on the clinical management of EGFR-mutant…

  39. IASLC LCC - Early Stage and Preoperative Care for NSCLC and EFGR in Mandarin

    · 48 min

    In this episode, recorded in Mandarin, host Dr. Chunxia Su leads a discussion about early stage and preoperative care for patients with NSCLC with an EGFR mutation. Guests: Wenzhao Zhong, Deputy Prensendent of…

  40. IASLC - TTLC_Molecular Tumor Board

    · 55 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung Cancer (TTLC)…

  41. Live from TTLC 2026: ADCs Controversies

    · 39 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guest Dr. Sam Rosner examine controversies around antibody-drug conjugates (ADCs) live from the 2026 Targeted Therapies of Lung Cancer (TTLC)…

  42. LCC in French_Virtual Tumor Board - EFGR NSCLC (1)

    · 43 min

    As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Angela Botticella and Dr. Jean Yannis Perentes. The tumor board focuses on the…

  43. Virtual Tumor Board: EGFR-mutant NSCLC

    · 48 min

    In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Sara Pilotto and Dr. Jonathan Riess for a virtual tumor board discussion on the management of metastatic EGFR exon 19 NSCLC . Using a…

  44. Controversies in the Management of Lung Cancer: Comorbidities

    · 48 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores controversies in managing lung cancer patients with comorbidities – those often underrepresented in clinical trials – with Dr. Hina Khan and…

  45. • Live from TTLC 2026: Emerging Molecular Targets in Non-Small Cell Lung Cancer (NSCLC)

    · 42 min

    In this episode of Lung Cancer Considered, host Dr. Narjust Florez explores the evolving landscape of emerging molecular targets in NSCLC with Dr. Kelsey Pan and Rajat Thawani, live from the Targeted Therapies of Lung…

  46. Virtual Tumor Board: Current Treatment for Small Cell Lung Cancer (SCLC)

    · 37 min

    This episode of Lung Cancer Considered focuses on a case of a patient with extensive stage SCLC. SCLC is a highly lethal subtype of lung cancer, accounting for about 13% of new lung cancer diagnoses with high…

  47. IASLC Global Policy Update

    · 55 min

    This episode examines the role public policy plays in impacting lung cancer treatment and research. The world has made tremendous progress in the treatment of lung cancer over the past decade, and much of that progress…

  48. • LCC in Cantonese: Updates in Surgical Approaches and Techniques in Early-Stage Lung Cancer

    · 55 min

    As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with two expert cardiothoracic surgeons, Dr. Ben Li, Professor from The First…

  49. What do I need to know about AI? Discussing the Role of AI in Thoracic Oncology

    · 45 min

    This episode of Lung Cancer Considered examines how artificial intelligence is being incorporated into patient care and what the future holds for this emerging technology. We will be discussing: • Is AI the right move…

  50. Lung Cancer Considered: Lung Cancer Care in Areas of Conflict and War

    · 48 min

    This episode of Lung Cancer Considered, hosted by Dr. Narjust Florez, examines the challenges of delivering lung cancer care in areas affected by war and displacement with guests Dr. Julie Gralow and Dr. Rafal…

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them. Explicit shows are for adult profiles only, and children’s profiles hear only children’s shows. More about this list.